Description
Used in the treatment of:
- HER2-positive early or metastatic breast cancer
- HER2-positive gastric or gastroesophageal junction adenocarcinoma
Trastuzumab (Herhope) is a monoclonal antibody that binds specifically to HER2 receptors, suppressing tumor cell proliferation and mediating immune destruction of cancer cells.



